Global Angiogenesis Modulators Market Research Report 2025(Status and Outlook)

March 2025 | 170 pages | ID: G7854CF11458EN
Bosson Research

Abstracts

Report Overview

Angiogenesis modulators are a class of pharmaceutical agents that regulate the formation of new blood vessels in the body. These substances can either stimulate or inhibit angiogenesis, depending on the desired therapeutic outcome. Angiogenesis plays a crucial role in various physiological processes such as wound healing, embryonic development, and the growth of solid tumors. By targeting the angiogenic process, these modulators have the potential to treat a wide range of diseases, including cancer, cardiovascular disorders, and chronic inflammatory conditions. The market for angiogenesis modulators is characterized by a diverse range of products, including small molecule drugs, biologics, and gene therapies, each offering unique mechanisms of action and therapeutic benefits.

The market for angiogenesis modulators is driven by several key factors. One of the primary drivers is the increasing prevalence of cancer and other angiogenesis-related diseases worldwide. As the demand for more effective and targeted treatment options continues to rise, there is a growing need for innovative angiogenesis modulators that can provide better clinical outcomes with fewer side effects. Additionally, advancements in biotechnology and drug discovery technologies have enabled the development of novel angiogenesis modulators with improved efficacy and safety profiles. Moreover, collaborations between academic research institutions, pharmaceutical companies, and regulatory agencies have facilitated the translation of basic science discoveries into clinically viable angiogenesis modulators. At the same time, the expanding pipeline of angiogenesis modulators in various stages of development indicates a promising future for this market, with opportunities for growth and innovation in the coming years.

This report provides a deep insight into the global Angiogenesis Modulators market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Angiogenesis Modulators Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Angiogenesis Modulators market in any manner.

Global Angiogenesis Modulators Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Celgene Corporation (USA)

Eisai (Japan)

Amgen

Inc. (USA)

Genentech

Inc. (USA)

GlaxoSmithKline plc (UK)

Bayer Pharma AG (Germany)

Bionomics Ltd. (Australia)

CASI Pharmaceuticals

Inc. (USA)

AstraZeneca plc (UK)

Eli Lilly and Company (USA)

F.Hoffmann-La Roche AG (Switzerland)

Market Segmentation (by Type)

Angiogenesis Inhibitors

Angiogenesis Stimulators

Angiogenin

Others

Market Segmentation (by Application)

Breast Cancer

Colorectal Cancer

Lung Cancer

Prostate Cancer

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Angiogenesis Modulators Market
• Overview of the regional outlook of the Angiogenesis Modulators Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Angiogenesis Modulators Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Angiogenesis Modulators
1.2 Key Market Segments
1.2.1 Angiogenesis Modulators Segment by Type
1.2.2 Angiogenesis Modulators Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Angiogenesis Modulators Market Overview
2.1 Global Market Overview
2.1.1 Global Angiogenesis Modulators Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Angiogenesis Modulators Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Angiogenesis Modulators Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Angiogenesis Modulators Product Life Cycle
3.3 Global Angiogenesis Modulators Sales by Manufacturers (2020-2025)
3.4 Global Angiogenesis Modulators Revenue Market Share by Manufacturers (2020-2025)
3.5 Angiogenesis Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Angiogenesis Modulators Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Angiogenesis Modulators Manufacturing Sites, Area Served, Product Type
3.8 Angiogenesis Modulators Market Competitive Situation and Trends
3.8.1 Angiogenesis Modulators Market Concentration Rate
3.8.2 Global 5 and 10 Largest Angiogenesis Modulators Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Angiogenesis Modulators Industry Chain Analysis
4.1 Angiogenesis Modulators Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Angiogenesis Modulators Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Angiogenesis Modulators Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Angiogenesis Modulators Market
5.7 ESG Ratings of Leading Companies
6 Angiogenesis Modulators Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Angiogenesis Modulators Sales Market Share by Type (2020-2025)
6.3 Global Angiogenesis Modulators Market Size Market Share by Type (2020-2025)
6.4 Global Angiogenesis Modulators Price by Type (2020-2025)
7 Angiogenesis Modulators Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Angiogenesis Modulators Market Sales by Application (2020-2025)
7.3 Global Angiogenesis Modulators Market Size (M USD) by Application (2020-2025)
7.4 Global Angiogenesis Modulators Sales Growth Rate by Application (2020-2025)
8 Angiogenesis Modulators Market Sales by Region
8.1 Global Angiogenesis Modulators Sales by Region
8.1.1 Global Angiogenesis Modulators Sales by Region
8.1.2 Global Angiogenesis Modulators Sales Market Share by Region
8.2 Global Angiogenesis Modulators Market Size by Region
8.2.1 Global Angiogenesis Modulators Market Size by Region
8.2.2 Global Angiogenesis Modulators Market Size Market Share by Region
8.3 North America
8.3.1 North America Angiogenesis Modulators Sales by Country
8.3.2 North America Angiogenesis Modulators Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Angiogenesis Modulators Sales by Country
8.4.2 Europe Angiogenesis Modulators Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Angiogenesis Modulators Sales by Region
8.5.2 Asia Pacific Angiogenesis Modulators Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Angiogenesis Modulators Sales by Country
8.6.2 South America Angiogenesis Modulators Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Angiogenesis Modulators Sales by Region
8.7.2 Middle East and Africa Angiogenesis Modulators Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Angiogenesis Modulators Market Production by Region
9.1 Global Production of Angiogenesis Modulators by Region(2020-2025)
9.2 Global Angiogenesis Modulators Revenue Market Share by Region (2020-2025)
9.3 Global Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Angiogenesis Modulators Production
9.4.1 North America Angiogenesis Modulators Production Growth Rate (2020-2025)
9.4.2 North America Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Angiogenesis Modulators Production
9.5.1 Europe Angiogenesis Modulators Production Growth Rate (2020-2025)
9.5.2 Europe Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Angiogenesis Modulators Production (2020-2025)
9.6.1 Japan Angiogenesis Modulators Production Growth Rate (2020-2025)
9.6.2 Japan Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Angiogenesis Modulators Production (2020-2025)
9.7.1 China Angiogenesis Modulators Production Growth Rate (2020-2025)
9.7.2 China Angiogenesis Modulators Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Celgene Corporation (USA)
10.1.1 Celgene Corporation (USA) Basic Information
10.1.2 Celgene Corporation (USA) Angiogenesis Modulators Product Overview
10.1.3 Celgene Corporation (USA) Angiogenesis Modulators Product Market Performance
10.1.4 Celgene Corporation (USA) Business Overview
10.1.5 Celgene Corporation (USA) SWOT Analysis
10.1.6 Celgene Corporation (USA) Recent Developments
10.2 Eisai (Japan)
10.2.1 Eisai (Japan) Basic Information
10.2.2 Eisai (Japan) Angiogenesis Modulators Product Overview
10.2.3 Eisai (Japan) Angiogenesis Modulators Product Market Performance
10.2.4 Eisai (Japan) Business Overview
10.2.5 Eisai (Japan) SWOT Analysis
10.2.6 Eisai (Japan) Recent Developments
10.3 Amgen
10.3.1 Amgen Basic Information
10.3.2 Amgen Angiogenesis Modulators Product Overview
10.3.3 Amgen Angiogenesis Modulators Product Market Performance
10.3.4 Amgen Business Overview
10.3.5 Amgen SWOT Analysis
10.3.6 Amgen Recent Developments
10.4 Inc. (USA)
10.4.1 Inc. (USA) Basic Information
10.4.2 Inc. (USA) Angiogenesis Modulators Product Overview
10.4.3 Inc. (USA) Angiogenesis Modulators Product Market Performance
10.4.4 Inc. (USA) Business Overview
10.4.5 Inc. (USA) Recent Developments
10.5 Genentech
10.5.1 Genentech Basic Information
10.5.2 Genentech Angiogenesis Modulators Product Overview
10.5.3 Genentech Angiogenesis Modulators Product Market Performance
10.5.4 Genentech Business Overview
10.5.5 Genentech Recent Developments
10.6 Inc. (USA)
10.6.1 Inc. (USA) Basic Information
10.6.2 Inc. (USA) Angiogenesis Modulators Product Overview
10.6.3 Inc. (USA) Angiogenesis Modulators Product Market Performance
10.6.4 Inc. (USA) Business Overview
10.6.5 Inc. (USA) Recent Developments
10.7 GlaxoSmithKline plc (UK)
10.7.1 GlaxoSmithKline plc (UK) Basic Information
10.7.2 GlaxoSmithKline plc (UK) Angiogenesis Modulators Product Overview
10.7.3 GlaxoSmithKline plc (UK) Angiogenesis Modulators Product Market Performance
10.7.4 GlaxoSmithKline plc (UK) Business Overview
10.7.5 GlaxoSmithKline plc (UK) Recent Developments
10.8 Bayer Pharma AG (Germany)
10.8.1 Bayer Pharma AG (Germany) Basic Information
10.8.2 Bayer Pharma AG (Germany) Angiogenesis Modulators Product Overview
10.8.3 Bayer Pharma AG (Germany) Angiogenesis Modulators Product Market Performance
10.8.4 Bayer Pharma AG (Germany) Business Overview
10.8.5 Bayer Pharma AG (Germany) Recent Developments
10.9 Bionomics Ltd. (Australia)
10.9.1 Bionomics Ltd. (Australia) Basic Information
10.9.2 Bionomics Ltd. (Australia) Angiogenesis Modulators Product Overview
10.9.3 Bionomics Ltd. (Australia) Angiogenesis Modulators Product Market Performance
10.9.4 Bionomics Ltd. (Australia) Business Overview
10.9.5 Bionomics Ltd. (Australia) Recent Developments
10.10 CASI Pharmaceuticals
10.10.1 CASI Pharmaceuticals Basic Information
10.10.2 CASI Pharmaceuticals Angiogenesis Modulators Product Overview
10.10.3 CASI Pharmaceuticals Angiogenesis Modulators Product Market Performance
10.10.4 CASI Pharmaceuticals Business Overview
10.10.5 CASI Pharmaceuticals Recent Developments
10.11 Inc. (USA)
10.11.1 Inc. (USA) Basic Information
10.11.2 Inc. (USA) Angiogenesis Modulators Product Overview
10.11.3 Inc. (USA) Angiogenesis Modulators Product Market Performance
10.11.4 Inc. (USA) Business Overview
10.11.5 Inc. (USA) Recent Developments
10.12 AstraZeneca plc (UK)
10.12.1 AstraZeneca plc (UK) Basic Information
10.12.2 AstraZeneca plc (UK) Angiogenesis Modulators Product Overview
10.12.3 AstraZeneca plc (UK) Angiogenesis Modulators Product Market Performance
10.12.4 AstraZeneca plc (UK) Business Overview
10.12.5 AstraZeneca plc (UK) Recent Developments
10.13 Eli Lilly and Company (USA)
10.13.1 Eli Lilly and Company (USA) Basic Information
10.13.2 Eli Lilly and Company (USA) Angiogenesis Modulators Product Overview
10.13.3 Eli Lilly and Company (USA) Angiogenesis Modulators Product Market Performance
10.13.4 Eli Lilly and Company (USA) Business Overview
10.13.5 Eli Lilly and Company (USA) Recent Developments
10.14 F.Hoffmann-La Roche AG (Switzerland)
10.14.1 F.Hoffmann-La Roche AG (Switzerland) Basic Information
10.14.2 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product Overview
10.14.3 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product Market Performance
10.14.4 F.Hoffmann-La Roche AG (Switzerland) Business Overview
10.14.5 F.Hoffmann-La Roche AG (Switzerland) Recent Developments
11 Angiogenesis Modulators Market Forecast by Region
11.1 Global Angiogenesis Modulators Market Size Forecast
11.2 Global Angiogenesis Modulators Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Angiogenesis Modulators Market Size Forecast by Country
11.2.3 Asia Pacific Angiogenesis Modulators Market Size Forecast by Region
11.2.4 South America Angiogenesis Modulators Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Angiogenesis Modulators by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Angiogenesis Modulators Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Angiogenesis Modulators by Type (2026-2033)
12.1.2 Global Angiogenesis Modulators Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Angiogenesis Modulators by Type (2026-2033)
12.2 Global Angiogenesis Modulators Market Forecast by Application (2026-2033)
12.2.1 Global Angiogenesis Modulators Sales (K MT) Forecast by Application
12.2.2 Global Angiogenesis Modulators Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Angiogenesis Modulators Market Size Comparison by Region (M USD)
Table 5. Global Angiogenesis Modulators Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Angiogenesis Modulators Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Angiogenesis Modulators Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Angiogenesis Modulators Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiogenesis Modulators as of 2024)
Table 10. Global Market Angiogenesis Modulators Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Angiogenesis Modulators Manufacturing Sites and Area Served
Table 12. Manufacturers Angiogenesis Modulators Product Type
Table 13. Global Angiogenesis Modulators Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Angiogenesis Modulators Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Angiogenesis Modulators Sales by Type (K MT)
Table 25. Global Angiogenesis Modulators Market Size by Type (M USD)
Table 26. Global Angiogenesis Modulators Sales (K MT) by Type (2020-2025)
Table 27. Global Angiogenesis Modulators Sales Market Share by Type (2020-2025)
Table 28. Global Angiogenesis Modulators Market Size (M USD) by Type (2020-2025)
Table 29. Global Angiogenesis Modulators Market Size Share by Type (2020-2025)
Table 30. Global Angiogenesis Modulators Price (USD/MT) by Type (2020-2025)
Table 31. Global Angiogenesis Modulators Sales (K MT) by Application
Table 32. Global Angiogenesis Modulators Market Size by Application
Table 33. Global Angiogenesis Modulators Sales by Application (2020-2025) & (K MT)
Table 34. Global Angiogenesis Modulators Sales Market Share by Application (2020-2025)
Table 35. Global Angiogenesis Modulators Market Size by Application (2020-2025) & (M USD)
Table 36. Global Angiogenesis Modulators Market Share by Application (2020-2025)
Table 37. Global Angiogenesis Modulators Sales Growth Rate by Application (2020-2025)
Table 38. Global Angiogenesis Modulators Sales by Region (2020-2025) & (K MT)
Table 39. Global Angiogenesis Modulators Sales Market Share by Region (2020-2025)
Table 40. Global Angiogenesis Modulators Market Size by Region (2020-2025) & (M USD)
Table 41. Global Angiogenesis Modulators Market Size Market Share by Region (2020-2025)
Table 42. North America Angiogenesis Modulators Sales by Country (2020-2025) & (K MT)
Table 43. North America Angiogenesis Modulators Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Angiogenesis Modulators Sales by Country (2020-2025) & (K MT)
Table 45. Europe Angiogenesis Modulators Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Angiogenesis Modulators Sales by Region (2020-2025) & (K MT)
Table 47. Asia Pacific Angiogenesis Modulators Market Size by Region (2020-2025) & (M USD)
Table 48. South America Angiogenesis Modulators Sales by Country (2020-2025) & (K MT)
Table 49. South America Angiogenesis Modulators Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Angiogenesis Modulators Sales by Region (2020-2025) & (K MT)
Table 51. Middle East and Africa Angiogenesis Modulators Market Size by Region (2020-2025) & (M USD)
Table 52. Global Angiogenesis Modulators Production (K MT) by Region(2020-2025)
Table 53. Global Angiogenesis Modulators Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Angiogenesis Modulators Revenue Market Share by Region (2020-2025)
Table 55. Global Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. North America Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Europe Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Japan Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. China Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Celgene Corporation (USA) Basic Information
Table 61. Celgene Corporation (USA) Angiogenesis Modulators Product Overview
Table 62. Celgene Corporation (USA) Angiogenesis Modulators Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. Celgene Corporation (USA) Business Overview
Table 64. Celgene Corporation (USA) SWOT Analysis
Table 65. Celgene Corporation (USA) Recent Developments
Table 66. Eisai (Japan) Basic Information
Table 67. Eisai (Japan) Angiogenesis Modulators Product Overview
Table 68. Eisai (Japan) Angiogenesis Modulators Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 69. Eisai (Japan) Business Overview
Table 70. Eisai (Japan) SWOT Analysis
Table 71. Eisai (Japan) Recent Developments
Table 72. Amgen Basic Information
Table 73. Amgen Angiogenesis Modulators Product Overview
Table 74. Amgen Angiogenesis Modulators Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Amgen Business Overview
Table 76. Amgen SWOT Analysis
Table 77. Amgen Recent Developments
Table 78. Inc. (USA) Basic Information
Table 79. Inc. (USA) Angiogenesis Modulators Product Overview
Table 80. Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Inc. (USA) Business Overview
Table 82. Inc. (USA) Recent Developments
Table 83. Genentech Basic Information
Table 84. Genentech Angiogenesis Modulators Product Overview
Table 85. Genentech Angiogenesis Modulators Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Genentech Business Overview
Table 87. Genentech Recent Developments
Table 88. Inc. (USA) Basic Information
Table 89. Inc. (USA) Angiogenesis Modulators Product Overview
Table 90. Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Inc. (USA) Business Overview
Table 92. Inc. (USA) Recent Developments
Table 93. GlaxoSmithKline plc (UK) Basic Information
Table 94. GlaxoSmithKline plc (UK) Angiogenesis Modulators Product Overview
Table 95. GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. GlaxoSmithKline plc (UK) Business Overview
Table 97. GlaxoSmithKline plc (UK) Recent Developments
Table 98. Bayer Pharma AG (Germany) Basic Information
Table 99. Bayer Pharma AG (Germany) Angiogenesis Modulators Product Overview
Table 100. Bayer Pharma AG (Germany) Angiogenesis Modulators Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Bayer Pharma AG (Germany) Business Overview
Table 102. Bayer Pharma AG (Germany) Recent Developments
Table 103. Bionomics Ltd. (Australia) Basic Information
Table 104. Bionomics Ltd. (Australia) Angiogenesis Modulators Product Overview
Table 105. Bionomics Ltd. (Australia) Angiogenesis Modulators Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Bionomics Ltd. (Australia) Business Overview
Table 107. Bionomics Ltd. (Australia) Recent Developments
Table 108. CASI Pharmaceuticals Basic Information
Table 109. CASI Pharmaceuticals Angiogenesis Modulators Product Overview
Table 110. CASI Pharmaceuticals Angiogenesis Modulators Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. CASI Pharmaceuticals Business Overview
Table 112. CASI Pharmaceuticals Recent Developments
Table 113. Inc. (USA) Basic Information
Table 114. Inc. (USA) Angiogenesis Modulators Product Overview
Table 115. Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Inc. (USA) Business Overview
Table 117. Inc. (USA) Recent Developments
Table 118. AstraZeneca plc (UK) Basic Information
Table 119. AstraZeneca plc (UK) Angiogenesis Modulators Product Overview
Table 120. AstraZeneca plc (UK) Angiogenesis Modulators Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 121. AstraZeneca plc (UK) Business Overview
Table 122. AstraZeneca plc (UK) Recent Developments
Table 123. Eli Lilly and Company (USA) Basic Information
Table 124. Eli Lilly and Company (USA) Angiogenesis Modulators Product Overview
Table 125. Eli Lilly and Company (USA) Angiogenesis Modulators Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 126. Eli Lilly and Company (USA) Business Overview
Table 127. Eli Lilly and Company (USA) Recent Developments
Table 128. F.Hoffmann-La Roche AG (Switzerland) Basic Information
Table 129. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product Overview
Table 130. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 131. F.Hoffmann-La Roche AG (Switzerland) Business Overview
Table 132. F.Hoffmann-La Roche AG (Switzerland) Recent Developments
Table 133. Global Angiogenesis Modulators Sales Forecast by Region (2026-2033) & (K MT)
Table 134. Global Angiogenesis Modulators Market Size Forecast by Region (2026-2033) & (M USD)
Table 135. North America Angiogenesis Modulators Sales Forecast by Country (2026-2033) & (K MT)
Table 136. North America Angiogenesis Modulators Market Size Forecast by Country (2026-2033) & (M USD)
Table 137. Europe Angiogenesis Modulators Sales Forecast by Country (2026-2033) & (K MT)
Table 138. Europe Angiogenesis Modulators Market Size Forecast by Country (2026-2033) & (M USD)
Table 139. Asia Pacific Angiogenesis Modulators Sales Forecast by Region (2026-2033) & (K MT)
Table 140. Asia Pacific Angiogenesis Modulators Market Size Forecast by Region (2026-2033) & (M USD)
Table 141. South America Angiogenesis Modulators Sales Forecast by Country (2026-2033) & (K MT)
Table 142. South America Angiogenesis Modulators Market Size Forecast by Country (2026-2033) & (M USD)
Table 143. Middle East and Africa Angiogenesis Modulators Sales Forecast by Country (2026-2033) & (Units)
Table 144. Middle East and Africa Angiogenesis Modulators Market Size Forecast by Country (2026-2033) & (M USD)
Table 145. Global Angiogenesis Modulators Sales Forecast by Type (2026-2033) & (K MT)
Table 146. Global Angiogenesis Modulators Market Size Forecast by Type (2026-2033) & (M USD)
Table 147. Global Angiogenesis Modulators Price Forecast by Type (2026-2033) & (USD/MT)
Table 148. Global Angiogenesis Modulators Sales (K MT) Forecast by Application (2026-2033)
Table 149. Global Angiogenesis Modulators Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Angiogenesis Modulators
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Angiogenesis Modulators Market Size (M USD), 2024-2033
Figure 5. Global Angiogenesis Modulators Market Size (M USD) (2020-2033)
Figure 6. Global Angiogenesis Modulators Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Angiogenesis Modulators Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Angiogenesis Modulators Product Life Cycle
Figure 13. Angiogenesis Modulators Sales Share by Manufacturers in 2024
Figure 14. Global Angiogenesis Modulators Revenue Share by Manufacturers in 2024
Figure 15. Angiogenesis Modulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Angiogenesis Modulators Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Angiogenesis Modulators Revenue in 2024
Figure 18. Industry Chain Map of Angiogenesis Modulators
Figure 19. Global Angiogenesis Modulators Market PEST Analysis
Figure 20. Global Angiogenesis Modulators Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Angiogenesis Modulators Market Share by Type
Figure 27. Sales Market Share of Angiogenesis Modulators by Type (2020-2025)
Figure 28. Sales Market Share of Angiogenesis Modulators by Type in 2024
Figure 29. Market Size Share of Angiogenesis Modulators by Type (2020-2025)
Figure 30. Market Size Share of Angiogenesis Modulators by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Angiogenesis Modulators Market Share by Application
Figure 33. Global Angiogenesis Modulators Sales Market Share by Application (2020-2025)
Figure 34. Global Angiogenesis Modulators Sales Market Share by Application in 2024
Figure 35. Global Angiogenesis Modulators Market Share by Application (2020-2025)
Figure 36. Global Angiogenesis Modulators Market Share by Application in 2024
Figure 37. Global Angiogenesis Modulators Sales Growth Rate by Application (2020-2025)
Figure 38. Global Angiogenesis Modulators Sales Market Share by Region (2020-2025)
Figure 39. Global Angiogenesis Modulators Market Size Market Share by Region (2020-2025)
Figure 40. North America Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Angiogenesis Modulators Sales Market Share by Country in 2024
Figure 43. North America Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Angiogenesis Modulators Market Size Market Share by Country in 2024
Figure 45. U.S. Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Angiogenesis Modulators Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Angiogenesis Modulators Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Angiogenesis Modulators Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Angiogenesis Modulators Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Angiogenesis Modulators Sales Market Share by Country in 2024
Figure 53. Europe Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Angiogenesis Modulators Market Size Market Share by Country in 2024
Figure 55. Germany Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Angiogenesis Modulators Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Angiogenesis Modulators Sales Market Share by Region in 2024
Figure 67. Asia Pacific Angiogenesis Modulators Market Size Market Share by Region in 2024
Figure 68. China Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Angiogenesis Modulators Sales and Growth Rate (K MT)
Figure 79. South America Angiogenesis Modulators Sales Market Share by Country in 2024
Figure 80. South America Angiogenesis Modulators Market Size and Growth Rate (M USD)
Figure 81. South America Angiogenesis Modulators Market Size Market Share by Country in 2024
Figure 82. Brazil Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Angiogenesis Modulators Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Angiogenesis Modulators Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Angiogenesis Modulators Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Angiogenesis Modulators Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Angiogenesis Modulators Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Angiogenesis Modulators Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Angiogenesis Modulators Production Market Share by Region (2020-2025)
Figure 103. North America Angiogenesis Modulators Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Angiogenesis Modulators Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Angiogenesis Modulators Production (K MT) Growth Rate (2020-2025)
Figure 106. China Angiogenesis Modulators Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Angiogenesis Modulators Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Angiogenesis Modulators Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Angiogenesis Modulators Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Angiogenesis Modulators Market Share Forecast by Type (2026-2033)
Figure 111. Global Angiogenesis Modulators Sales Forecast by Application (2026-2033)
Figure 112. Global Angiogenesis Modulators Market Share Forecast by Application (2026-2033)